“Omega-3 Fatty Acid Supplementation and Serum Lipid Profile in Patients with Metabolic Syndrome: A Randomized, Placebo-Controlled Trial”, JCNFS, vol. 5, no. 1, pp. 9–16, Nov. 2022, doi: 10.5281/zenodo.22335668.